Nissha Co., Ltd. (hereinafter, “Nissha”) held the Ordinary General Meeting of Shareholders of the 106th Business Term on March 21, 2025, at the Global Headquarters of Nissha. After the business reports, three proposals were deliberated and all of them were approved and carried as raised in the original.

We consider that the General Meeting of Shareholders is a valuable opportunity for communication with our shareholders. In order to enhance communication with them, we accepted questions from the shareholders prior to the event and delivered the General Meeting by live streaming.

On the day of the event, 90 shareholders attended at the venue, and the General Meeting took 80 minutes. Among the questions received prior to the event, those regarding stock prices and shareholder returns, measures for human capital, and initiatives to enhance brand recognition were addressed. The chairman responded to these questions. 5 shareholders at the venue subsequently asked 6 questions regarding the impact of exchange rate fluctuations on performance, sales by region overseas, the impact of the Trump administration's policies, compensation paid to Directors of the Board, and risk management in the pharmaceutical business. The chairman and directors in charge responded to each question.

After the General Meeting, we held a brief session on the management objectives and strategies. Junya Suzuki, Chairman of the Board and Group CEO, explained our medium-term prospects in the priority markets for us.

We would like to express our deep appreciation to all shareholders who attended at the venue or viewed on the live streaming.